Vraylar (cariprazine) is used to treat several mental health conditions in adults, including:
- Manic or mixed episodes in bipolar I disorder
- Depressive episodes in bipolar I disorder
- Schizophrenia
- Major depressive disorder (depression), as an add-on therapy with an antidepressant
Vraylar is typically taken as a once-daily oral capsule, and its effects on mood and behavior are thought to be related to its impact on brain chemicals such as dopamine and serotonin[1][2][3][5]. It is FDA-approved for alleviating a range of symptoms in both bipolar and depressive disorders, as well as for improving the psychiatric symptoms experienced in schizophrenia[1][2][5].